Article Details

Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company

Retrieved on: 2018-07-01 18:41:05

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company. View article details on hiswai:

Excerpt

<div>The <b>Baupost Group</b>, L.L.C., who owns up to 21.4% of outstanding Keryx common stock has also agreed to convert outstanding convertible notes of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up